Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1026 496
Brodalumab 351 0
Certolizumab 118 0
Efalizumab 35 0
Etanercept 309 63
Golimumab 25 0
Guselkumab 744 0
Infliximab 101 1
Ixekizumab 578 0
Risankizumab 411 0
Secukinumab 1402 0
Tildrakizumab 487 0
Ustekinumab 724 0
Apremilast 578 0
Ciclosporin 396 0
Fumaderm 2637 0
Skilarence 2152 0
Methotrexate 3538 0
Tofacitinib 2 0
other systemics 341 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers